TLX 041
Alternative Names: TLX-041Latest Information Update: 10 Dec 2023
At a glance
- Originator Tulex Pharmaceuticals
- Class Urologics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Genitourinary disorders
Most Recent Events
- 28 Nov 2023 Preclinical trials in Genitourinary disorders in USA (PO), prior to November 2023 (Tulex Pharmaceuticals pipeline, November 2023)